[1]KRISHNAN A,BERTHELET J,RENAUD E,et al.Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas[J].Nat Commun,2020,11(1):2056.
[2] ROTH MJ,WEAVER TD,SHAKIR MK,et al.Neck pain as an initial presentation of medullary thyroid cancer[J].Endocr Pract,2019,26(1):141.
[3] XING M.Molecular pathogenesis and mechanisms of thyroid cancer[J].Nat Rev Cancer,2013,13(3):184-199.
[4]TORRESAN F,CAVEDON E,MIAN C,et al.Long-term outcome after surgery for medullary thyroid carcinoma:a single-center experience[J].World J Surg,2018,42(2):367-375.
[5]薛松,王浩,蔡兆根,等.甲状腺微小髓样癌8例临床病理分析[J].临床与实验病理学杂志,2019,35(7):795-798.
XUE S,WANG H,CAI ZG,et al.Thyroid micromedullary carcinoma:clinicopathologic study of 8 cases[J].J Clin Exp Pathol,2019,35(7):795-798.
[6] LUSTER M,MUSHOLT TJ.Thyroid gland:thyroid surgery and radioiodine ablation-the surgeon's role[J].Nat Rev Endocrinol,2013,9(3):140-141.
[7] 逯泓智,陈宇,张广旭,等.甲状腺微小乳头状癌热消融技术研究进展及现状分析[J].现代肿瘤医学,2022,30(20):3799-3802.
LU HZ,CHEN Y,ZHANG GX,et al.Current situation and outlook of radiofrequency ablation technique in papillary thyroid microcarcinoma[J].Modern Oncology,2022,30(20):3799-3802.
[8]朱莹,王蓓.甲状腺微小乳头状癌的临床治疗现状[J].济宁医学院学报,2022,45(06):386-391.
ZHU Y,WANG B.Clinical treatment status of papillary thyroid microcarcinoma[J].J Jining Med Univ,2022,45(06):386-391.
[9]肖思齐,吴宪吉,沈珂羽,等.术前评估因素在中高危甲状腺微小乳头状癌治疗方式决策中的作用[J].中国普外基础与临床杂志,2023,30(05):620-625.
XIAO SQ,WU XJ,SHEN KY,et al.Role of preoperative assessment factors for decisions on treatment modalities in papillary thyroid microcarcinoma with intermediate-and high-risk[J].Chinese Journal of Bases and Clinics in General Surgery,2023,30(05):620-625.
[10] 陆一丹,时开元,欧笛,等.甲状腺微小癌预后风险评估与治疗决策的研究进展[J].中国肿瘤,2020,29(12):962-969.
LU YD,SHI KY,OU D,et al.Progress on prognostic risk assessment and treatment strategy for thyroid microcarcinoma[J].China Cancer,2020,29(12):962-969.
[11]中国抗癌协会甲状腺癌专业委员会.中国抗癌协会甲状腺癌整合诊治指南(2022精简版)[J].中国肿瘤临床,2023,50(7):325-330.
China Anti-Cancer Association Committee of Thyroid Oncology.China Anti-Cancer Association guidelines for holistic integrative management of thyroid cancer (2022 abridged version)[J].Chin J Clin Oncol,2023,50(7):325-330.
[12] HAHN SY,SHIN JH,OH YL,et al.Ultrasonographic characteristics of medullary thyroid carcinoma according to nodule size:application of the Korean Thyroid Imaging Reporting and Data System and American Thyroid Association guidelines[J].Acta Radiol,2021,62(4):474-482.
[13]LI J,LI H,YANG Y,et al.The KWAK TI-RADS and 2015 ATA guidelines for medullary thyroid carcinoma:Combined with cell block-assisted ultrasound-guided thyroid fine-needle aspiration[J].Clin Endocrinol,2020,92(5):450-460.
[14] KHAN STA,MAQSOOD S.Role of ultrasound in thyroid pathologies[J].IAIM,2018,5(4):131-138.
[15] WANG H,LIU M,YANG J,et al.High frequency ultrasound features and pathological characteristics of medullary thyroid carcinoma[J].Pak J Pharm Sci,2016,29(6):2269-2271.
[16] 周明炀,费晓春,詹维伟,等.甲状腺微小乳头状癌常见超声表现的病理学基础[J].中华医学超声杂志(电子版),2014,11(5):383-387.
ZHOU MY,FEI XC,ZHAN WW,et al.Common characteristic of papillary microcarcinoma of thyroid in ultrasound and pathology[J].Chin J Med Ultrasound(Electronic Edition),2014,11(5):383-387.
[17]CHO KE,GWEON HM,PARK AY,et al.Ultrasonographic features of medullary thyroid carcinoma:Do they correlate with pre and postoperative calcitonin levels[J].Asian Pac J Cancer Prev,2016,17(7):3357-3362.
[18]骆洪浩,马步云,赵海娜,等.甲状腺髓样癌的超声图像特征分析[J].临床超声医学杂志,2019,21(7):544-546,565.
LUO HH,MA BY,ZHAO HN,et al.Ultrasonographic features of medullary thyroid carcinoma[J].J Clin Ultrasound in Med,2019,21(7):544-546,565.
[19]CHOI N,MOON WJ,LEE JH,et al.Ultrasonographic findings of medullary thyroid cancer:differences according to tumor size and correlation with fine needle aspiration results[J].Acta Radiol,2011,52(3):312-316.
[20] TRIMBOLI P,NASROLLAH N,AMENDOLA S,et al.Should we use ultrasound features associated with papillary thyroid cancer in diagnosing medullary thyroid cancer[J].Endocr J,2012,59(6):503-508.
[21] 朱佳琳,赵静,魏玺,等.改良甲状腺影像报告及数据系统在甲状腺髓样癌诊断中的价值[J].中华肿瘤杂志,2017,39(8):618-623.
ZHU JL,ZHAO J,WEI X,et al.Value of modified TI-RADS in the diagnosis of medullary thyroid carcinoma[J].Chinese Journal of Oncology,2017,39(8):618-623.
[22] CAPPELLI C,CASTELLANO M,PIROLA I,et al.Thyroid nodule shape suggests malignancy[J].Eur J Endocrinlol,2006,155(1):27-31.
[23] 张帆,陈文,薛恒.纵横比对于不同大小甲状腺乳头状癌的超声诊断价值研究[J].中国超声医学杂志,2020,36(1):8-10.
ZHANG F,CHEN W,XUE H.Diagnostic value of taller-than-wide sign on ultrasound in thyroid papillary carcinoma with different sizes[J].Chinese J Ultrasound Med,2020,36(1):8-10.
[24] LIU MJ,LIU ZF,HOU YY,et al.Ultrasonographic characteristics of medullary thyroid carcinoma:a comparison with papillary thyroid carcinoma[J].Oncotarget,2017,8(16):27520-27528.